Could Heterozygous Beta Thalassemia Provide Protection Against Multiple Sclerosis?

Creative Commons License

Cikrikcioglu M. A., Ozcan M. E., Halac G., Gultepe I., Celik K., Sekin Y., ...Daha Fazla

MEDICAL SCIENCE MONITOR, cilt.22, ss.4854-4858, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22
  • Basım Tarihi: 2016
  • Doi Numarası: 10.12659/msm.898192
  • Dergi Adı: MEDICAL SCIENCE MONITOR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.4854-4858
  • Anahtar Kelimeler: beta-Thalassemia, Multiple Sclerosis, Platelet Aggregation, SYSTEMIC-LUPUS-ERYTHEMATOSUS, PLATELET ACTIVATION, TRAIT
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Background: Heterozygous beta thalassemia (HBT) has been proposed to increase the risk of developing autoimmune disease. Our aim in this study was to examine the prevalence of HBT among multiple sclerosis (MS) patients.